Literature DB >> 26612648

Plasma PAF-AH (PLA2G7): Biochemical Properties, Association with LDLs and HDLs, and Regulation of Expression.

Diana M Stafforini1.   

Abstract

This chapter is focused on the plasma form of PAF-acetylhydrolase (PAF-AH), a lipoprotein-bound, calcium-independent phospholipase A2 activity also referred to as lipoprotein-associated phospholipase A2 and PLA2G7. PAF-AH catalyzes the removal of the acyl group at the sn-2 position of PAF and truncated phospholipids generated in settings of inflammation and oxidant stress. Here, I discuss current knowledge related to the structural features of this enzyme, including the molecular basis for association with lipoproteins and susceptibility to oxidative inactivation. The circulating form of PAF-AH is constitutively active and its expression is upregulated by mediators of inflammation at the transcriptional level. Several new mechanisms of regulation have been identified in recent years, including effects mediated by PPARs, VEGFR, and the state of cellular differentiation. Moreover, I discuss recent studies describing significant variations in the structure and regulation of PAF-AH from diverse species, which is likely to have important implications for the function of this enzyme in vivo.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cellular differentiation; HDL; Inflammation; LDL; Lipopolysaccharide; Lipoprotein-associated phospholipase A(2); Lipoproteins; Lp-PLA(2); Oxidation; PAF-AH; PLA2G7

Year:  2015        PMID: 26612648     DOI: 10.1016/bs.enz.2015.09.004

Source DB:  PubMed          Journal:  Enzymes        ISSN: 1874-6047


  11 in total

Review 1.  Lipoprotein-associated phospholipase A2: The story continues.

Authors:  Fubao Huang; Kai Wang; Jianhua Shen
Journal:  Med Res Rev       Date:  2019-05-29       Impact factor: 12.944

Review 2.  Frailty in Aging and the Search for the Optimal Biomarker: A Review.

Authors:  Magdalena Sepúlveda; Diego Arauna; Francisco García; Cecilia Albala; Iván Palomo; Eduardo Fuentes
Journal:  Biomedicines       Date:  2022-06-16

3.  The role of Lp-PLA2 and biochemistry parameters as potential biomarkers of coronary artery disease in Asian South-Indians: a case-control study.

Authors:  Sai Giridhar Sairam; Srikanth Sola; Asha Barooah; Sai Kiran Javvaji; Jiten Jaipuria; Vijayalakshmi Venkateshan; Janardhana Chelli; Carani Balaraman Sanjeevi
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

4.  Systemic Platelet-Activating Factor-Receptor Agonism Enhances Non-Melanoma Skin Cancer Growth.

Authors:  Eric Romer; Anita Thyagarajan; Smita Krishnamurthy; Christine M Rapp; Langni Liu; Katherine Fahy; Azeezat Awoyemi; Ravi P Sahu
Journal:  Int J Mol Sci       Date:  2018-10-11       Impact factor: 5.923

5.  Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy.

Authors:  Pauline Morigny; Doris Kaltenecker; Julia Zuber; Juliano Machado; Lisa Mehr; Foivos-Filippos Tsokanos; Hanna Kuzi; Chris D Hermann; Michael Voelkl; German Monogarov; Christoph Springfeld; Victor Laurent; Bernd Engelmann; Helmut Friess; Inka Zörnig; Achim Krüger; Jeroen Krijgsveld; Olga Prokopchuk; Søren Fisker Schmidt; Maria Rohm; Stephan Herzig; Mauricio Berriel Diaz
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-08-23       Impact factor: 12.910

Review 6.  Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease.

Authors:  Diego Estrada-Luna; María Araceli Ortiz-Rodriguez; Lizett Medina-Briseño; Elizabeth Carreón-Torres; Jeannett Alejandra Izquierdo-Vega; Ashutosh Sharma; Juan Carlos Cancino-Díaz; Oscar Pérez-Méndez; Helen Belefant-Miller; Gabriel Betanzos-Cabrera
Journal:  Molecules       Date:  2018-10-23       Impact factor: 4.411

Review 7.  Lp-PLA2, a new biomarker of vascular disorders in metabolic diseases.

Authors:  Alessandro De Stefano; Liliana Mannucci; Federica Tamburi; Carmine Cardillo; Francesca Schinzari; Valentina Rovella; Steven Nisticò; Luigi Bennardo; Nicola Di Daniele; Manfredi Tesauro
Journal:  Int J Immunopathol Pharmacol       Date:  2019 Jan-Dec       Impact factor: 3.219

8.  Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow.

Authors:  Yao-Dong Ding; Yu-Qiang Pei; Rui Wang; Jia-Xing Yang; Yin-Xin Zhao; Xiao-Li Liu; Hua Shen; Qian Ma; Shuo Zhang; Hai-Long Ge
Journal:  BMC Cardiovasc Disord       Date:  2020-05-27       Impact factor: 2.298

Review 9.  New Insights Into the Pathologic Roles of the Platelet-Activating Factor System.

Authors:  Jeffrey B Travers; Joyce G Rohan; Ravi P Sahu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-15       Impact factor: 6.055

10.  Thioredoxin Domain Containing 5 Suppression Elicits Serum Amyloid A-Containing High-Density Lipoproteins.

Authors:  Javier Sánchez-Marco; Roberto Martínez-Beamonte; Alicia De Diego; Tania Herrero-Continente; Cristina Barranquero; Carmen Arnal; Joaquín Surra; María A Navarro; Jesús Osada
Journal:  Biomedicines       Date:  2022-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.